DOCSLIB.ORG

CWS/5/6 (In Russian)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
CWS/5/6 (In Russian) R CWS/5/6 ОРИГИНАЛ: АНГЛИЙСКИЙ ДАТА: 21 АПРЕЛЯ 2017 Г. Комитет по стандартам ВОИС (КСВ) Пятая сессия Женева, 29 мая – 2 июня 2017 г. ПЕРЕСМОТР СТАНДАРТА ВОИС ST.26 Документ подготовлен Секретариатом 1. На своей четвертой возобновленной сессии, состоявшейся в марте 2016 г. в Женеве, Комитет по стандартам ВОИС (КСВ) принял стандарт ВОИС ST.26 « Рекомендуемый стандарт представления перечней нуклеотидных и аминокислотных последовательностей с использованием языка XML (расширяемого языка разметки)». В связи с этим КСВ согласился на изменение описания задачи № 44: « Подготовить рекомендации в отношении порядка перехода со стандарта ВОИС ST.25 на стандарт ST.26; и, по мере необходимости, предложение по пересмотру стандарта ВОИС ST.26». (См. пункты 49–53 и 82–84 документа CWS/4BIS/16.) 2. В соответствии с новым описанием задачи № 44 Целевая группа по SEQL провела обсуждения по вопросу о пересмотре стандарта ВОИС ST.26; Европейское патентное ведомство (ЕПВ) как руководитель Целевой группы предоставило отчет о ходе работы Целевой группы, который воспроизведен в приложении I к настоящему документу. 3. По итогам обсуждений Целевая группа по SEQL представила на рассмотрение и, при необходимости, утверждение КСВ окончательные предложения о пересмотре стандарта ST.26, которые включают предложения об изменениях в основном тексте стандарта ST.26 и его приложениях I–III, а также предложение о принятии нового приложения VI (методический документ). Следует отметить, что приложения IV и V стандарта ST.26 остаются без изменений (и поэтому не прилагаются). Предлагаемые изменения воспроизведены в приложении II к настоящему документу в отношении основного текста стандарта ST.26 и его приложений I–II (которые озаглавлены соответственно как «ST.26, приложение I», и «ST.26, приложение II»); что касается приложения III к ST.26, то Целевая группа по SEQL предлагает изменить регистр CWS/5/6 стр. 2 двухбуквенных языковых кодов с верхнего на нижний и таким образом привести их в соответствие с двухбуквенными кодами, определенными в стандарте ISO 639, например изменить двухбуквенный код «EN» для английского языка на «en». Следует отметить, что в том случае, если КСВ одобрит предложенное изменение, новая версия стандарта ST.26 станет версией 1.1 (приложение III к ST.26 к настоящему документу не прилагается). 4. КСВ предлагается: (a) принять к сведению содержание настоящего документа и отчет о ходе работы Целевой группы по SEQL, содержащийся в Приложении I к настоящему документу; и (b) рассмотреть предлагаемый пересмотренный стандарт ВОИС ST.26, упомянутый в пункте 3 выше и воспроизведенный в приложении II к настоящему документу, и принять решение о его утверждении. [Приложение I следует] CWS/5/6 ПРИЛОЖЕНИЕ I ОТЧЕТ ЦЕЛЕВОЙ ГРУППЫ ПО SEQL О ПЕРЕСМОТРЕ СТАНДАРТА ВОИС ST.26 Документ подготовлен Европейским патентным ведомством (ЕПВ) СПРАВОЧНАЯ ИНФОРМАЦИЯ 1. Целевая группа по перечням последовательностей была создана Комитетом по стандартам ВОИС (КСВ) на его первой сессии (25–29 октября 2010 г.) для выполнения задачи № 44 (см. пункт 29 документа CWS/1/10): 2. «Подготовить рекомендацию по представлению перечней нуклеотидных и аминокислотных последовательностей с использованием расширяемого языка разметки (XML) для ее принятия в качестве стандарта ВОИС. Предлагаемый текст нового стандарта ВОИС должен быть дополнен сообщением о последствиях принятия такого стандарта для применения текущего стандарта ВОИС ST.25, включая предложения об изменениях, которые необходимо внести в стандарт ST.25». 3. Целевой группе было также поручено: «Провести консультации с соответствующим органом PCT относительно возможных последствий такого стандарта для приложения C к Административной инструкции к РСТ». 4. Обязанности руководителя Целевой группы были возложены на Европейское патентное ведомство (ЕПВ); новый стандарт ВОИС под названием стандарт ST.26 был официально принят на четвертой возобновленной сессии КСВ (CWS/4BIS) в марте 2016 г. 5. КСВ на своей четвертой возобновленной сессии (21-24 марта 2016 г.) утвердил следующее измененное описание задачи № 44: «Подготовить рекомендации в отношении порядка перехода со стандарта ВОИС ST.25 на стандарт ST.26; и, при необходимости, предложение по пересмотру стандарта ВОИС ST.26». ОТЧЕТ О ХОДЕ РАБОТЫ 6. После принятия стандарта ST.26 на возобновленной четвертой сессии КСВ Целевая группа провела два раунда обсуждений: восьмой раунд был посвящен поиску путей дополнительного усовершенствования принятого стандарта с тем, чтобы обеспечить его эффективность в ходе практического применения, а в ходе девятого раунда были рассмотрены вопросы, связанные с переходом (от стандарта ST.25 к стандарту ST.26). За это время Целевая группа провела ряд веб-конференций и два неофициальных заседания в Женеве (23 марта и 9 сентября 2016 г.). 7. Целевая группа уделила особое внимание пересмотру принятого стандарта ST.26 в целях упростить его использование заявителями и ведомствами. Пересмотренный стандарт ST.26, представленный на утверждение КСВ на его пятой сессии, предусматривает следующие важнейшие изменения: - в стандарт внесены уточнения, касающиеся последовательностей пептидных нуклеиновых кислот (ПНА) и вариантов; - добавлен методический документ (приложение VI), призванный способствовать единообразному применению и толкованию стандарта ведомствами и заявителями; - обновлено приложение I «Контролируемая лексика» с целью его приведения в соответствие с таблицей характеристик INSDC V.10.6, опубликованной в ноябре 2016 г.; CWS/5/6 Приложение I, стр. 2 - добавлены или переформулированы комментарии в приложении II (DTD) с целью их уточнения и приведения в соответствие с INSDC DTD v1.5; - улучшен общий текст стандарта с учетом замечаний и комментариев, представленных в ходе публичных консультаций, проведенных ЕПВ, ЯПВ и ВПТЗ США в 2016/2017 гг. ДОРОЖНАЯ КАРТА 8. Получить на пятой сессии КСВ одобрение измененного/дополненного текста стандарта ST.26. 9. Получить на пятой сессии КСВ одобрение «Рекомендаций об обеспечении перехода от стандарта ВОИС ST.25 к стандарту ST.26». 10. Оказывать поддержку Международному бюро ВОИС путем его информирования о требованиях и мнениях пользователей об инструменте составления текста заявки. 11. Оказывать поддержку ВОИС в работе по пересмотру Административной инструкции к PCT с учетом изменений стандарта. 12. Работать над дальнейшим пересмотром стандарта ВОИС ST.26. Предлагается, чтобы дальнейший пересмотр стандарта не был обусловлен заранее определенным графиком и инициировался членами КСВ. [Annex II follows] CWS/5/6 ПРИЛОЖЕНИЕ II STANDARD ST.26 RECOMMENDED STANDARD FOR THE PRESENTATION OF NUCLEOTIDE AND AMINO ACID SEQUENCE LISTINGS USING XML (EXTENSIBLE MARKUP LANGUAGE) Version 1.01.1 Proposal presented by the SEQL Task Force for consideration and approval at the CWS/5 Adopted by the Committee on WIPO Standards (CWS) at its reconvened fourth session on March 24, 2016 Editorial Note prepared by the International Bureau The Committee on WIPO Standards (CWS) agreed to ask industrial property offices to postpone the implementation of this new WIPO Standard ST.26 until the recommendations for the transition from WIPO Standard ST.25 to the new Standard ST.26 is agreed on by the CWS at its next session to be held in 2017. Meanwhile, Standard ST.25 should continue to be used. The Standard is published for information purposes of industrial property offices other interested parties. TABLE OF CONTENTS INTRODUCTION ........................................................................................................................................................... 3 DEFINITIONS ................................................................................................................................................................ 3 SCOPE .......................................................................................................................................................................... 4 REFERENCES .............................................................................................................................................................. 5 PRESENTATIONREPRESENTATION OF SEQUENCES ............................................................................................. 5 Nucleotide sequences ................................................................................................................................................ 5 Amino acid sequences ............................................................................................................................................... 7 Presentation of special situations ............................................................................................................................... 9 STRUCTURE OF THE SEQUENCE LISTING IN XML .................................................................................................. 9 Root element ............................................................................................................................................................ 10 General information part ........................................................................................................................................... 10 Sequence data part .................................................................................................................................................. 13 Feature table ............................................................................................................................................................ 15 Feature keys ...........................................................................................................................................................
Load more

Recommended publications
  • (12) United States Patent (10) Patent No.: US 9,598.458 B2 Shimizu Et Al
    USO09598458B2 (12) United States Patent (10) Patent No.: US 9,598.458 B2 Shimizu et al. (45) Date of Patent: Mar. 21, 2017 (54) ASYMMETRICAUXILLARY GROUP 3,687,808 A 8/1972 Merigan et al. 3,745,162 A 7/1973 Helsley 4,022,791 A 5/1977 Welch, Jr. (71) Applicant: NYTE SCIENCES JAPAN, 4,113,869 A 9, 1978 Gardner ... Kagoshima-shi (JP) 4.415,732 A 1 1/1983 Caruthers et al. 4,458,066 A 7/1984 Caruthers et al. (72) Inventors: Mamoru Shimizu, Uruma (JP); 4,500,707 A 2f1985 Caruthers et al. Takeshi Wada, Kashiwa (JP) 4,542,142 A 9, 1985 Martel et al. 4,659,774 A 4, 1987 Webb et al. 4,663,328 A 5, 1987 Lafon (73) Assignee: YESCIENCES JAPAN, 4,668,777. A 5/1987 Caruthers et al. ... Kagoshima-shi (JP) 4,725,677 A 2/1988 Koster et al. 4,735,949 A 4, 1988 Domagala et al. (*) Notice: Subject to any disclaimer, the term of this 4,840,956 A 6/1989 Domagala et al. patent is extended or adjusted under 35 3:38 A . 3. EthOester Phet al. et al. U.S.C. 154(b) by 17 days. 4,973,679 A 1 1/1990 Caruthers et al. 4,981,957 A 1/1991 Lebleu et al. (21) Appl. No.: 14/414,604 5,047,524. A 9/1991 Andrus et al. 5,118,800 A 6/1992 Smith et al. (22) PCT Filed: Jul. 12, 2013 5,130,302 A 7/1992 Spielvogel et al.
    [Show full text]
  • Collagen and Elastin Fibres
    J Clin Pathol: first published as 10.1136/jcp.s3-12.1.49 on 1 January 1978. Downloaded from J. clin. Path., 31, Suppl. (Roy. Coll. Path.), 12, 49-58 Collagen and elastin fibres A. J. BAILEY From the Agricultural Research Council, Meat Research Institute, Langford, Bristol Although an understanding of the intracellular native collagen was generated from type I pro- biosynthesis of both collagen and elastin is of collagen. Whether this means that the two pro- considerable importance it is the subsequent extra- collagens are converted by different enzyme systems cellular changes involving fibrogenesis and cross- and the type III enzyme was deficient in these linking that ensure that these proteins ultimately fibroblast cultures, or that the processing of pro become the major supporting tissues of the body. type III is extremely slow, is not known. The latter This paper summarises the formation and stability proposal is consistent with the higher proportion of collagen and elastin fibres. of soluble pro type III extractable from tissue (Lenaers and Lapiere, 1975; Timpl et al., 1975). Collagen Basement membrane collagens, on the other hand, do not form fibres and this property may be The non-helical regions at the ends of the triple due to the retention of the non-helical extension helix of procollagen probably provide a number of peptides (Kefalides, 1973). In-vivo biosynthetic different intracellular functions-that is, initiating studies showing the absence of any extension peptide rapid formation of the triple helix; inhibiting intra- removal support this (Minor et al., 1976), but other cellular fibrillogenesis; and facilitating transmem- workers have reported that there is some cleavage brane movement.
    [Show full text]
  • Synthetic Polynucleotides Synthetische Polynukleotide Polynucleotides Synthetiques
    Europäisches Patentamt *EP000960192B1* (19) European Patent Office Office européen des brevets (11) EP 0 960 192 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.7: C12N 9/02, C12N 15/53, of the grant of the patent: A61K 38/43, C12N 9/06 09.11.2005 Bulletin 2005/45 (86) International application number: (21) Application number: 97933592.4 PCT/AU1997/000505 (22) Date of filing: 11.08.1997 (87) International publication number: WO 1998/006830 (19.02.1998 Gazette 1998/07) (54) SYNTHETIC POLYNUCLEOTIDES SYNTHETISCHE POLYNUKLEOTIDE POLYNUCLEOTIDES SYNTHETIQUES (84) Designated Contracting States: • SHARP P M ET AL: "The codon Adaptation AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC Index--a measure of directional synonymous NL PT SE codon usage bias, and its potential applications." NUCLEIC ACIDS RESEARCH. (30) Priority: 09.08.1996 AU PO156596 ENGLAND 11 FEB 1987, vol. 15, no. 3, 11 February 1987 (1987-02-11), pages 1281-1295, (43) Date of publication of application: XP001122356 ISSN: 0305-1048 01.12.1999 Bulletin 1999/48 • DATABASE SWISSPROT [Online] 1 December 1992 (1992-12-01) MARIANI T.J. ET AL.: (60) Divisional application: "Protein-lysine 6-oxidase precursor (EC 05000327.6 1.4.3.13) (Lysyl oxidase)." Database accession no. P28300 XP002229125 (73) Proprietor: THE UNIVERSITY OF SYDNEY • DATABASE EMBL [Online] EBI; 16 May 1992 Sydney, New South Wales 2006 (AU) (1992-05-16) MARIANI T.J. ET AL.: "Human lysyl oxidase (LOX) mRNA, complete cds." Database (72) Inventor: WEISS, Anthony, Steven accession no. M94054 XP002229126 Randwick, NSW 2031 (AU) • DATABASE EMBL [Online] EBI; 26 November 1993 (1993-11-26) HAMALAINEN E.R.
    [Show full text]
  • 5-Fluorocytosine/Isocytosine Monohydrate. the First Example of Isomorphic and Isostructural Co-Crystal of Pyrimidine Nucleobases
    crystals Article 5-Fluorocytosine/Isocytosine Monohydrate. The First Example of Isomorphic and Isostructural Co-Crystal of Pyrimidine Nucleobases Gustavo Portalone Department of Chemistry, ‘Sapienza’ University of Rome, 00185 Rome, Italy; [email protected]; Tel.: +396-4991-3715 Received: 1 October 2020; Accepted: 2 November 2020; Published: 3 November 2020 Abstract: To date, despite the crucial role played by cytosine, uracil, and thymine in the DNA/RNA replication process, no examples showing isomorphic and isostructural behavior among binary co-crystals of natural or modified pyrimidine nucleobases have been so far reported in the literature. In view of the relevance of biochemical and pharmaceutical compounds such as pyrimidine nucleobases and their 5-fluoroderivatives, co-crystals of the molecular complex formed by 5-fluorocytosine and isocytosine monohydrate, C H FN O C H N O H O, have been synthesized 4 4 3 · 4 5 3 · 2 by a reaction between 5-fluorocytosine and isocytosine. They represent the first example of isomorphic and isostructural binary co-crystals of pyrimidine nucleobases, as X-ray diffraction analysis shows structural similarities in the solid-state organization of molecules with that of the (1:1) 5-fluorocytosine/5-fluoroisocytosine monohydrate molecular complex, which differs solely in the H/F substitution at the C5 position of isocytosine. Molecules of 5-fluorocytosine and isocytosine are present in the crystal as 1H and 3H-ketoamino tautomers, respectively. They form almost coplanar WC base pairs through nucleobase-to-nucleobase DAA/ADD hydrogen bonding interactions, demonstrating that complementary binding enables the crystallization of specific tautomers. Additional peripheral hydrogen bonds involving all available H atom donor and acceptor sites of the water molecule give a three-dimensional polymeric structure.
    [Show full text]
  • Methods, Compounds, Compositions and Vehicles for Delivering 3-Amino-1-Propanesulfonic Acid
    (19) TZZ _ T (11) EP 2 862 581 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 22.04.2015 Bulletin 2015/17 A61K 47/48 (2006.01) C07K 5/06 (2006.01) C07K 5/08 (2006.01) C07C 309/15 (2006.01) (2006.01) (2006.01) (21) Application number: 14200552.9 C07D 207/16 C07D 209/20 C07D 217/24 (2006.01) C07D 233/64 (2006.01) (2006.01) (2006.01) (22) Date of filing: 12.10.2007 C07D 291/02 C07D 333/24 C12P 11/00 (2006.01) A61K 38/07 (2006.01) A61K 38/08 (2006.01) A61P 25/28 (2006.01) (84) Designated Contracting States: (72) Inventor: The designation of the inventor has not AT BE BG CH CY CZ DE DK EE ES FI FR GB GR yet been filed HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR (74) Representative: Hoffmann Eitle Patent- und Rechtsanwälte PartmbB (30) Priority: 12.10.2006 US 851039 P Arabellastraße 30 12.04.2007 US 911459 P 81925 München (DE) (62) Document number(s) of the earlier application(s) in Remarks: accordance with Art. 76 EPC: This application was filed on 30-12-2014 as a 07875176.5 / 2 089 417 divisional application to the application mentioned under INID code 62. (71) Applicant: BHI Limited Partnership Laval, QC H7V 4A7 (CA) (54) Methods, compounds, compositions and vehicles for delivering 3- amino-1-propanesulfonic acid (57) The invention relates to methods, compounds, that will yield or generate 3APS, either in vitro or in vivo.
    [Show full text]
  • Structural Studies of a Stable Parallel-Stranded DNA Duplex
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Biophysical Journal Volume 75 September 1998 1163–1171 1163 Structural Studies of a Stable Parallel-Stranded DNA Duplex Incorporating Isoguanine:Cytosine and Isocytosine:Guanine Basepairs by Nuclear Magnetic Resonance Spectroscopy Xiang-Lei Yang,* Hiroshi Sugiyama,# Shuji Ikeda,§ Isao Saito,§ and Andrew H.-J. Wang* *Department of Cell and Structural Biology, University of Illinois at Urbana-Champaign, Urbana, Illinois 61801 USA; #Institute for Medical and Dental Engineering, Tokyo Medical and Dental University, Tokyo 101-0062, Japan; and §Department of Synthetic Chemistry and Biological Chemistry, Faculty of Engineering, Kyoto University, Kyoto 606-8501, Japan ABSTRACT Isoguanine (2-hydroxyladenine) is a product of oxidative damage to DNA and has been shown to cause mutation. It is also a potent inducer of parallel-stranded DNA duplex structure. The structure of the parallel-stranded DNA duplex (PS-duplex) 5Ј-d(TiGiCAiCiGiGAiCT) ϩ 5Ј-d(ACGTGCCTGA), containing the isoguanine (iG) and 5-methyl-isocytosine (iC) bases, has been determined by NMR refinement. All imino protons associated with the iG:C, G:iC, and A:T (except the two terminal A:T) basepairs are observed at 2°C, consistent with the formation of a stable duplex suggested by the earlier Tm measurements [Sugiyama, H., S. Ikeda, and I. Saito. 1996. J. Am. Chem. Soc. 118:9994–9995]. All basepairs are in the reverse Watson-Crick configuration. The structural characteristics of the refined PS-duplex are different from those of B-DNA. The PS duplex has two grooves with similar width (7.0 Å) and depth (7.7 Å), in contrast to the two distinct grooves (major groove width 11.7 Å, depth 8.5 Å, and minor groove width 5.7 Å, depth 7.5 Å) of B-DNA.
    [Show full text]
  • Revised ST.26 – 26/Oct/2016 ANNEX I
    Revised ST.26 – 26/Oct/2016 ANNEX I ST.26 - ANNEX I CONTROLLED VOCABULARY Final Draft TABLE OF CONTENTS SECTION 1: LIST OF NUCLEOTIDES ................................................................................................................................. 2 SECTION 2: LIST OF MODIFIED NUCLEOTIDES .............................................................................................................. 2 SECTION 3: LIST OF AMINO ACIDS ................................................................................................................................... 4 SECTION 4: LIST OF MODIFIED AND UNUSUAL AMINO ACIDS ..................................................................................... 5 SECTION 5: FEATURE KEYS FOR NUCLEIC SEQUENCES ............................................................................................ 6 SECTION 6: QUALIFIERS FOR NUCLEIC SEQUENCES ................................................................................................ 21 SECTION 7: FEATURE KEYS FOR AMINO ACID SEQUENCES ..................................................................................... 40 SECTION 8: QUALIFIERS FOR AMINO ACID SEQUENCES ........................................................................................... 47 SECTION 9: GENETIC CODE TABLES ............................................................................................................................. 48 Revised ST.26 – 26/Oct/2016 ANNEX I SECTION 1: LIST OF NUCLEOTIDES The nucleotide base codes to be used in sequence
    [Show full text]
  • Download PDF of Article
    research papers 7-Iodo-5-aza-7-deazaguanine ribonucleoside: crystal structure, physical properties, base-pair stability and functionalization ISSN 2053-2296 Dasharath Kondhare,a Simone Budow-Busse,a Constantin Daniliucb and Frank Seelaa,c* Received 19 February 2020 aLaboratory of Bioorganic Chemistry and Chemical Biology, Center for Nanotechnology, Heisenbergstrasse 11, 48149 Accepted 3 April 2020 Mu¨nster, Germany, bOrganisch-Chemisches Institut, Westfa¨lische Wilhelms-Universita¨tMu¨nster, Corrensstrasse 40, 48149 Mu¨nster, Germany, and cLaboratorium fu¨r Organische und Bioorganische Chemie, Institut fu¨r Chemie, Universita¨t Edited by D. S. Yufit, University of Durham, Osnabru¨ck, Barbarastrasse 7, 49069 Osnabru¨ck, Germany. *Correspondence e-mail: [email protected] England Keywords: 7-iodo-5-aza-7-deazaguanosine; The positional change of nitrogen-7 of the RNA constituent guanosine to the ribonucleoside; crystal structure; Hirshfeld bridgehead position-5 leads to the base-modified nucleoside 5-aza-7-deaza- surface analysis; base-pair prediction; crystal guanosine. Contrary to guanosine, this molecule cannot form Hoogsteen base packing; all-purine RNA; pKa values. pairs and the Watson–Crick proton donor site N3—H becomes a proton- acceptor site. This causes changes in nucleobase recognition in nucleic acids and CCDC reference: 1950946 has been used to construct stable ‘all-purine’ DNA and DNA with silver- Supporting information: this article has mediated base pairs. The present work reports the single-crystal X-ray structure supporting information at journals.iucr.org/c of 7-iodo-5-aza-7-deazaguanosine, C10H12IN5O5 (1). The iodinated nucleoside shows an anti conformation at the glycosylic bond and an N conformation (O40- endo) for the ribose moiety, with an antiperiplanar orientation of the 50-hydroxy group.
    [Show full text]
  • Program 1..154
    The 97th Annual Meeting of CSJ Program Chair: INOUE, Haruo（15：30～15：55） Room S1 1S1- 15 Medium and Long-Term Program Lecture Artificial Photosynthesis of Ammonia（RIES, Hokkaido Univ.）○MISAWA, Hiroaki （15:30～15:55） Fourth Building, Section B J11 Chair: INOUE, Haruo（15：55～16：20） 1S1- 16 Medium and Long-Term Program Lecture Mechanism of water-splitting by photosystem II using the energy of visible light（Grad. Sustainable and Functional Redox Chemistry Sch. Nat. Sci. Technol., Okayama Univ.）○SHEN, Jian-ren（15:55～ ） Thursday, March 16, AM 16:20 （9：30 ～9：35 ） Chair: TAMIAKI, Hitoshi（16：20～16：45） 1S1- 01 Special Program Lecture Opening Remarks（Sch. Mater. & 1S1- 17 Medium and Long-Term Program Lecture Excited State Chem. Tech., Tokyo Tech.）○INAGI, Shinsuke（09:30～09:35） Molecular Dynamics of Natural and Artificial Photosynthesis（Sch. Sci. Tech., Kwansei Gakuin Univ.）○HASHIMOTO, Hideki（16:20～16:45） Chair: ATOBE, Mahito（9：35 ～10：50） 1S1- 02 Special Program Lecture Polymer Redox Chemistry toward Chair: ISHITANI, Osamu（16：45～17：10） Functional Materials（Sch. Mater. & Chem. Tech., Tokyo Tech.）○INAGI, 1S1- 18 Medium and Long-Term Program Lecture Recent pro- Shinsuke（09:35～09:50） gress on artificial photosynthesis system based on semiconductor photocata- 1S1- 03 Special Program Lecture Organic Redox Chemistry Enables lysts（Grad. Sch. Eng., Kyoto Univ.）○ABE, Ryu（16:45～17:10） Automated Solution-Phase Synthesis of Oligosaccharides（Grad. Sch. Eng., Tottori Univ.）○NOKAMI, Toshiki（09:50～10:10） （17：10～17：20） 1S1- 04 Special Program Lecture Redox Regulation of Functional 1S1- 19 Medium and Long-Term Program Lecture Closing re- Dyes and Their Applications to Optoelectronic Devices（Fac.
    [Show full text]
  • Growth, Elastin Concentration, and Collagen Concentration of Perinatal Rat Lung: Effects of Dexamethasone
    003 1-3998/87/2 106-0603$02.00/0 PEDIATRIC RESEARCH Vol. 21, No. 6, 1987 Copyright O 1987 International Pediatric Research Foundation, Inc Printed in U.S. A. Growth, Elastin Concentration, and Collagen Concentration of Perinatal Rat Lung: Effects of Dexamethasone JEAN-CLAUDE SCHELLENBERG, GRAHAM C. LIGGINS, AND ALISTAIR W. STEWART Postgraduate School of Obstetrics and Gynaecology [J-C.S., G.C.L.] and Department of Community Health [A. W.S.], The University of Auckland, Auckland, New Zealand ABSTRACT. The ontogenesis of elastin and collagen ac- phological (8) or biochemical structural analysis is required. cumulation and growth of the lung were studied in Wistar Although elastin and collagen have been used as markers of rats from day 18 of gestation until day 30 postnatally. connective tissue structure of the lung in newborn and adolescent Dexamethasone phosphate 0.1 mg or normal saline solu- rats (9-12), no data are available on the fetal rat lung. The tion every 8 h for three doses was injected into pregnant present study reports the ontogenesis of collagen and elastin rats on day 17. The effects of treatment, age, and sex on accumulation in rat lung between day 18 of gestation and day lung wet weight, lung dry weight, body weight, DNA, 30 postpartum and investigates the effects of prenatal glucocor- protein and desmosine (estimated by radioimmunoassay), ticoid administration on growth and structural development of and hydroxyproline were determined in the offspring. Dex- the rat lung. A radioimmunoassay for the determination of amethasone inhibited lung growth and, to a lesser extent, desmosine, a specific cross-link amino acid of elastin (13) is body weight gain.
    [Show full text]
  • Excited-State Dynamics of Isocytosine: a Hybrid Case of Canonical Nucleobase Photodynamics Jacob A
    Letter Cite This: J. Phys. Chem. Lett. 2017, 8, 5184-5189 pubs.acs.org/JPCL Excited-State Dynamics of Isocytosine: A Hybrid Case of Canonical Nucleobase Photodynamics Jacob A. Berenbeim, Samuel Boldissar, Faady M. Siouri, Gregory Gate, Michael R. Haggmark, Briana Aboulache, Trevor Cohen, and Mattanjah S. de Vries* Department of Chemistry and Biochemistry, University of California, Santa Barbara, California 93106-9510, United States *S Supporting Information ABSTRACT: We present resonant two-photon ionization (R2PI) spectra of isocytosine (isoC) and pump−probe results on two of its tautomers. IsoC is one of a handful of alternative bases that have been proposed in scenarios of prebiotic chemistry. It is structurally similar to both cytosine (C) and guanine (G). We compare the excited-state dynamics with the Watson−Crick (WC) C and G tautomeric forms. These results suggest that the excited-state dynamics of WC form of G may primarily depend on the heterocyclic substructure of the pyrimidine moiety, which is chemically identical to isoC. For WC isoC we find a single excited-state decay with a rate of ∼1010 s−1, while the enol form has multiple decay rates, the fastest of which is 7 times slower than for WC isoC. The excited-state dynamics of isoC exhibits striking similarities with that of G, more so than with the photodynamics of C. ithout a fossil record of the prebiotic chemical world we W are left to conjecture to understand the roadmap that led to RNA and DNA. One of the factors that may have played a role in the prebiotic chemistry on an early earth is the photochemistry that could have been important before modern enzymatic repair and before the formation of the ozone − layer.1 6 Nucleobases, when absorbing ultraviolet (UV) radiation, tend to eliminate the resulting electronic excitation − by internal conversion (IC) in picoseconds (ps) or less.4,7 9 The availability of this rapid “safe” de-excitation pathway turns out to depend exquisitely on molecular structure.
    [Show full text]
  • Chirality Dependent Potency Enhancement and Structural Impact of Glycol Nucleic Acid Modification on Sirna † † † † † Mark K
    Article pubs.acs.org/JACS Chirality Dependent Potency Enhancement and Structural Impact of Glycol Nucleic Acid Modification on siRNA † † † † † Mark K. Schlegel,*, Donald J. Foster, Alexander V. Kel’in, Ivan Zlatev, Anna Bisbe, † † # † † ‡ Muthusamy Jayaraman, Jeremy G. Lackey, , Kallanthottathil G. Rajeev, Klaus Charisse,́Joel Harp, ‡ † ‡ † Pradeep S. Pallan, Martin A. Maier, Martin Egli, and Muthiah Manoharan*, † Alnylam Pharmaceuticals, 300 Third Street, Cambridge, Massachusetts 02142, United States ‡ Vanderbilt University School of Medicine, Department of Biochemistry, Nashville, Tennessee 37232, United States *S Supporting Information ABSTRACT: Here we report the investigation of glycol nucleic acid (GNA), an acyclic nucleic acid analogue, as a modification of siRNA duplexes. We evaluated the impact of (S)- or (R)-GNA nucleotide incorporation on RNA duplex structure by determining three individual crystal structures. These structures indicate that the (S)-nucleotide backbone adopts a conformation that has little impact on the overall duplex structure, while the (R)-nucleotide disrupts the phosphate backbone and hydrogen bonding of an adjacent base pair. In addition, the GNA-T nucleobase adopts a rotated conformation in which the 5-methyl group points into the minor groove, rather than the major groove as in a normal Watson−Crick base pair. This observation of reverse Watson−Crick base pairing is further supported by thermal melting analysis of GNA-C and GNA-G containing duplexes where it was demonstrated that a higher thermal stability was associated with isoguanine and isocytosine base pairing, respectively, over the canonical nucleobases. Furthermore, it was also shown that GNA nucleotide or dinucleotide incorporation increases resistance against snake venom phosphodiesterase. Consistent with the structural data, modification of an siRNA with (S)-GNA resulted in greater in vitro potencies over identical sequences containing (R)-GNA.
    [Show full text]